Olema Pharmaceuticals Inc (NASDAQ:OLMA) price on Thursday, April 10, rose 8.25% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.41.
A look at the stock’s price movement, the close in the last trading session was $3.15, moving within a range at $3.01 and $3.44. The beta value (5-Year monthly) was 2.109. Turning to its 52-week performance, $16.62 and $2.86 were the 52-week high and 52-week low respectively. Overall, OLMA moved -24.39% over the past month.
Olema Pharmaceuticals Inc’s market cap currently stands at around $233.02 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-17.
Turning to the stock’s technical picture we see that short term indicators suggest on average that OLMA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend OLMA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
OLMA’s current price about -10.56% and -24.90% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 35.88, while 7-day volatility ratio is 12.79% and 9.41% in the 30-day chart. Further, Olema Pharmaceuticals Inc (OLMA) has a beta value of 2.13, and an average true range (ATR) of 0.36. Analysts have given the company’s stock an average 52-week price target of $27, forecast between a low of $27 and high of $27. Looking at the price targets, the low is -691.79% off current price level while to achieve the yearly target high, price needs to move -691.79%. Nonetheless, investors will most likely welcome a -691.79% jump to $27 which is the analysts’ median price.
If we refocus on Olema Pharmaceuticals Inc (NASDAQ:OLMA), historical trading data shows that trading volumes averaged 1.3 over the past 10 days and 1.05 million over the past 3 months. The company’s latest data on shares outstanding shows there are 74.31 million shares.
The 20.05% of Olema Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 84.41% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.69 million on 2025-03-14, giving us a short ratio of 11.26. The data shows that as of 2025-03-14 short interest in Olema Pharmaceuticals Inc (OLMA) stood at 1972.0 of shares outstanding, with shares short rising to 8.22 million registered in 2025-02-14. Current price change has pushed the stock -41.51% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the OLMA stock continues to rise going into the next quarter.
